Clinical Cases in HER2+ Breast Cancer

home / expert-perspective-tumor-board / clinical-cases-in-her2-breast-cancer

Experts in breast oncology review 3 clinical cases of HER2+ breast cancer and discuss individualized treatment approaches for each patient.

Case 1: Early Stage HER2+ Breast Cancer

EP. 1: Case 1: Early Stage HER2+ Breast Cancer

Targeted Oncology
September 11th 2020

Watch

Case 1: Molecular Testing for HER2+ Breast Cancer

EP. 2: Case 1: Molecular Testing for HER2+ Breast Cancer

Targeted Oncology
September 11th 2020

Watch

Case 1: Neoadjuvant Therapy for Early-Stage HER2+ Breast Cancer

EP. 3: Case 1: Neoadjuvant Therapy for Early-Stage HER2+ Breast Cancer

Targeted Oncology
September 11th 2020

Watch

Case 1: Choosing Therapy for Early Stage HER2+ Breast Cancer 

EP. 4: Case 1: Choosing Therapy for Early Stage HER2+ Breast Cancer 

Targeted Oncology
September 11th 2020

Watch

Case 1: Adjuvant Treatment for Residual Disease in Early Stage HER2+ Breast Cancer 

EP. 5: Case 1: Adjuvant Treatment for Residual Disease in Early Stage HER2+ Breast Cancer 

Targeted Oncology
September 11th 2020

Watch

Case 1: Adjuvant Therapy After pCR in Early Stage HER2+ Breast Cancer 

EP. 6: Case 1: Adjuvant Therapy After pCR in Early Stage HER2+ Breast Cancer 

Targeted Oncology
September 11th 2020

Watch

Case 1: Adjuvant Trials for HER2+ Breast Cancer

EP. 7: Case 1: Adjuvant Trials for HER2+ Breast Cancer

Targeted Oncology
September 11th 2020

Watch

Case 1: De-Escalation of Adjuvant Anti-HER2 Therapy for Breast Cancer 

EP. 8: Case 1: De-Escalation of Adjuvant Anti-HER2 Therapy for Breast Cancer 

Targeted Oncology
September 11th 2020

Watch

Case 1: Subcutaneous Trastuzumab-Pertuzumab for HER2+ Breast Cancer 

EP. 9: Case 1: Subcutaneous Trastuzumab-Pertuzumab for HER2+ Breast Cancer 

Targeted Oncology
September 11th 2020

Watch

Case 2: Relapsed/Refractory HR-/HER2+ Breast Cancer

EP. 10: Case 2: Relapsed/Refractory HR-/HER2+ Breast Cancer

Targeted Oncology
September 11th 2020

Watch

Case 2: Previously Treated HER2+ Breast Cancer

EP. 11: Case 2: Previously Treated HER2+ Breast Cancer

Targeted Oncology
September 11th 2020

Watch

Case 2: Later-Line Treatment of HER2+ Breast Cancer

EP. 12: Case 2: Later-Line Treatment of HER2+ Breast Cancer

Targeted Oncology
September 11th 2020

Watch

Case 2: Impact of Brain Metastases in HER2+ Breast Cancer

EP. 13: Case 2: Impact of Brain Metastases in HER2+ Breast Cancer

Targeted Oncology
September 11th 2020

Watch

Case 2: Risk Factors for Brain Metastases in HER2+ Breast Cancer

EP. 14: Case 2: Risk Factors for Brain Metastases in HER2+ Breast Cancer

Targeted Oncology
September 11th 2020

Watch

Case 2: Adverse Effects of Treatments for HER2+ Breast Cancer

EP. 15: Case 2: Adverse Effects of Treatments for HER2+ Breast Cancer

Targeted Oncology
September 11th 2020

Watch

Case 2: Sequencing Treatments for HER2+ Breast Cancer

EP. 16: Case 2: Sequencing Treatments for HER2+ Breast Cancer

Targeted Oncology
September 11th 2020

Watch

Case 2: Novel Agents in Late-Stage Clinical Trials for HER2+ MBC

EP. 17: Case 2: Novel Agents in Late-Stage Clinical Trials for HER2+ MBC

Targeted Oncology
September 11th 2020

Watch

Case 3: Triple-Positive Metastatic Breast Cancer

EP. 18: Case 3: Triple-Positive Metastatic Breast Cancer

Targeted Oncology
September 11th 2020

Watch

Case 3: Distant Metastases in Triple-Positive Breast Cancer

EP. 19: Case 3: Distant Metastases in Triple-Positive Breast Cancer

Targeted Oncology
September 11th 2020

Watch